Grundmann Hajo, Aires-de-Sousa Marta, Boyce John, Tiemersma Edine
Centre for Infectious Diseases Epidemiology, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Lancet. 2006 Sep 2;368(9538):874-85. doi: 10.1016/S0140-6736(06)68853-3.
Staphylococcus aureus is a gram-positive bacterium that colonises the skin and is present in the anterior nares in about 25-30% of healthy people. Dependent on its intrinsic virulence or the ability of the host to contain its opportunistic behaviour, S aureus can cause a range of diseases in man. The bacterium readily acquires resistance against all classes of antibiotics by one of two distinct mechanisms: mutation of an existing bacterial gene or horizontal transfer of a resistance gene from another bacterium. Several mobile genetic elements carrying exogenous antibiotic resistance genes might mediate resistance acquisition. Of all the resistance traits S aureus has acquired since the introduction of antimicrobial chemotherapy in the 1930s, meticillin resistance is clinically the most important, since a single genetic element confers resistance to the most commonly prescribed class of antimicrobials--the beta-lactam antibiotics, which include penicillins, cephalosporins, and carbapenems.
金黄色葡萄球菌是一种革兰氏阳性菌,可定植于皮肤,约25% - 30%的健康人鼻腔前部存在该菌。根据其内在毒力或宿主抑制其机会性致病行为的能力,金黄色葡萄球菌可在人类中引发一系列疾病。该细菌可通过两种不同机制之一轻易获得对各类抗生素的耐药性:现有细菌基因发生突变,或耐药基因从另一种细菌水平转移。几种携带外源抗生素耐药基因的可移动遗传元件可能介导耐药性的获得。自20世纪30年代引入抗菌化疗以来,金黄色葡萄球菌获得的所有耐药性状中,耐甲氧西林在临床上最为重要,因为单一遗传元件可使其对最常用的一类抗菌药物——β-内酰胺类抗生素(包括青霉素、头孢菌素和碳青霉烯类)产生耐药性。